Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisoprolol after myocardial infarction with preserved left ventricular function
2026-525475-96-00Phase 4Authorised
- Sponsor
- UZ Leuven
- Start
- Jun 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bisoprolol in myocardial infarction (MI) (2 arms), sponsored by UZ Leuven. Primary endpoint: SF-36 Mental and Physical Component Summary at 3 months. Planned start Jun 2026; status: authorised.
02
Drugs
bisoprolol
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2026-525475-96-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-525475-96-00.